Inverse Relation of Serum Helicobacter Pylori Antibody Titres and Extent of Intestinal Metaplasia

Overview

Journal J Clin Pathol

Specialty Pathology

Date 1996 Feb 1

PMID 8655674

Citations 8

Authors

H Osawa

F Inoue

Y Yoshida

Affiliations

Soon will be listed here.

Abstract

Aims: To clarify the relation between the serum titre of anti-Helicobacter pylori (H pylori) antibody and the extent of intestinal metaplasia of the gastric mucosa.

Methods: The serum anti-H pylori IgG titres of 95 asymptomatic individuals (mean age 65 years) undergoing an annual health examination were measured and compared with the extent of intestinal metaplasia (absent, moderate, or extensive), determined by examination of multiple endoscopic mucosal biopsy specimens. Serum pepsinogen I (PGI) levels, as a marker for gastric atrophy, were also measured.

Results: The prevalence of seropositivity for H pylori antibody was high (> 80%), regardless of the extent of metaplasia. However, there was a negative association between the extent of metaplasia and the anti-H pylori titre: 75% of the subjects in the group without metaplasia had high (3+) antibody levels, as did 43% with moderate, and 37% with extensive metaplasia (absent v extensive). The inverse relation between the titre and the extent of metaplasia was evident when examined in those with normal PGI (> 30 ng/ml), whereas no such relation was apparent in subjects with low PGI (< or = 30 ng/ml).

Conclusions: The anti-H pylori titre correlates inversely with the extent of intestinal metaplasia, particularly in subjects with less marked gastric atrophy.

Citing Articles

Correlation analysis of gastric mucosal lesions with infection and its virulence genotype in Guiyang, Guizhou province, China.

Hu Y, Wang Y, Mi M, Deng Z, Zhu J, Liu Q Ann Transl Med. 2023; 10(24):1320.

PMID: 36660645 PMC: 9843376. DOI: 10.21037/atm-22-5553.

Current status and future perspective of linked color imaging for gastric cancer screening: a literature review.

Yashima K, Onoyama T, Kurumi H, Takeda Y, Yoshida A, Kawaguchi K J Gastroenterol. 2022; 58(1):1-13.

PMID: 36287268 PMC: 9825522. DOI: 10.1007/s00535-022-01934-z.

Linked Color Imaging and Blue Laser Imaging for Upper Gastrointestinal Screening.

Osawa H, Miura Y, Takezawa T, Ino Y, Khurelbaatar T, Sagara Y Clin Endosc. 2018; 51(6):513-526.

PMID: 30384402 PMC: 6283759. DOI: 10.5946/ce.2018.132.

Linked color imaging can enhance recognition of early gastric cancer by high color contrast to surrounding gastric intestinal metaplasia.

Fukuda H, Miura Y, Osawa H, Takezawa T, Ino Y, Okada M J Gastroenterol. 2018; 54(5):396-406.

PMID: 30291440 DOI: 10.1007/s00535-018-1515-6.

Cross-reactivity between immune responses to Helicobacter bilis and Helicobacter pylori in a population in Thailand at high risk of developing cholangiocarcinoma.

Pisani P, Whary M, Nilsson I, Sriamporn S, Wadstrom T, Fox J Clin Vaccine Immunol. 2008; 15(9):1363-8.

PMID: 18596203 PMC: 2546680. DOI: 10.1128/CVI.00132-08.

References

SAMLOFF I, Varis K, Ihamaki T, Siurala M, Rotter J . Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology. 1982; 83(1 Pt 2):204-9. View

Wyatt J, Shallcross T, Crabtree J, Heatley R . Helicobacter pylori, gastritis, and peptic ulceration in the elderly. J Clin Pathol. 1992; 45(12):1070-4. PMC: 494999. DOI: 10.1136/jcp.45.12.1070. View

Ichinose M, Miki K, Furihata C, Kageyama T, Hayashi R, Niwa H . Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders. Clin Chim Acta. 1982; 126(2):183-91. DOI: 10.1016/0009-8981(82)90034-1. View

Warren J, Marshall B . Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983; 1(8336):1273-5. View

Tsutsumi Y, Nagura H, Watanabe K . Immune aspects of intestinal metaplasia of the stomach: an immunohistochemical study. Virchows Arch A Pathol Anat Histopathol. 1984; 403(4):345-59. DOI: 10.1007/BF00737285. View

Rathbone B, Wyatt J, Worsley B, Shires S, Trejdosiewicz L, Heatley R . Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia. Gut. 1986; 27(6):642-7. PMC: 1433340. DOI: 10.1136/gut.27.6.642. View

Wyatt J, Rathbone B, Heatley R . Local immune response to gastric Campylobacter in non-ulcer dyspepsia. J Clin Pathol. 1986; 39(8):863-70. PMC: 500112. DOI: 10.1136/jcp.39.8.863. View

Howson C, Hiyama T, Wynder E . The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev. 1986; 8:1-27. DOI: 10.1093/oxfordjournals.epirev.a036288. View

JOHNSTON B, Reed P, Ali M . Campylobacter like organisms in duodenal and antral endoscopic biopsies: relationship to inflammation. Gut. 1986; 27(10):1132-7. PMC: 1433854. DOI: 10.1136/gut.27.10.1132. View

10.

Marshall B, Warren J, Francis G, Langton S, Goodwin C, Blincow E . Rapid urease test in the management of Campylobacter pyloridis-associated gastritis. Am J Gastroenterol. 1987; 82(3):200-10. View

11.

STEMMERMANN G, SAMLOFF I, Nomura A, Heilbrun L . Serum pepsinogens I and II and stomach cancer. Clin Chim Acta. 1987; 163(2):191-8. DOI: 10.1016/0009-8981(87)90022-2. View

12.

Miki K, Ichinose M, Shimizu A, Huang S, Oka H, Furihata C . Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn. 1987; 22(2):133-41. DOI: 10.1007/BF02774209. View

13.

Newell D, JOHNSTON B, Ali M, Reed P . An enzyme-linked immunosorbent assay for the serodiagnosis of Campylobacter pylori-associated gastritis. Scand J Gastroenterol Suppl. 1988; 142:53-7. DOI: 10.3109/00365528809091714. View

14.

Graham D . Campylobacter pylori and peptic ulcer disease. Gastroenterology. 1989; 96(2 Pt 2 Suppl):615-25. DOI: 10.1016/s0016-5085(89)80057-5. View

15.

Parsonnet J, Vandersteen D, Goates J, Sibley R, Pritikin J, Chang Y . Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst. 1991; 83(9):640-3. DOI: 10.1093/jnci/83.9.640. View

16.

Crabtree J, Shallcross T, Heatley R, Wyatt J . Evaluation of a commercial ELISA for serodiagnosis of Helicobacter pylori infection. J Clin Pathol. 1991; 44(4):326-8. PMC: 496910. DOI: 10.1136/jcp.44.4.326. View

17.

Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T . Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology. 1992; 102(3):760-6. DOI: 10.1016/0016-5085(92)90156-s. View

18.

Kosunen T, Seppala K, Sarna S, Sipponen P . Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet. 1992; 339(8798):893-5. DOI: 10.1016/0140-6736(92)90929-w. View

19.

Craanen M, Blok P, Dekker W, Ferwerda J, Tytgat G . Subtypes of intestinal metaplasia and Helicobacter pylori. Gut. 1992; 33(5):597-600. PMC: 1379284. DOI: 10.1136/gut.33.5.597. View

20.

Hoek F, Noach L, Rauws E, Tytgat G . Evaluation of the performance of commercial test kits for detection of Helicobacter pylori antibodies in serum. J Clin Microbiol. 1992; 30(6):1525-8. PMC: 265322. DOI: 10.1128/jcm.30.6.1525-1528.1992. View